William J Boyle

Summary

Publications

  1. ncbi RANK-L and RANK: T cells, bone loss, and mammalian evolution
    Lars E Theill
    Inflammation Drug Discovery Research, One Amgen Center Drive, Thousand Oaks, California 91320-1789, USA
    Annu Rev Immunol 20:795-823. 2002
  2. ncbi Osteoclast differentiation and activation
    William J Boyle
    Protein Pathways, Inc, Woodland Hills, California 91367, USA
    Nature 423:337-42. 2003
  3. ncbi Osteoprotegerin, an endogenous antiosteoclast factor for protecting bone in rheumatoid arthritis
    Brad Bolon
    Amgen, Inc, Thousand Oaks, California 91320, USA
    Arthritis Rheum 46:3121-35. 2002
  4. ncbi Role of RANK ligand in mediating increased bone resorption in early postmenopausal women
    Guitty Eghbali-Fatourechi
    Endocrine Research Unit, Mayo Clinic and Foundation, 200 First Street SW, Rochester, MN 55905, USA
    J Clin Invest 111:1221-30. 2003

Collaborators

Detail Information

Publications4

  1. ncbi RANK-L and RANK: T cells, bone loss, and mammalian evolution
    Lars E Theill
    Inflammation Drug Discovery Research, One Amgen Center Drive, Thousand Oaks, California 91320-1789, USA
    Annu Rev Immunol 20:795-823. 2002
    ..Modulation of these systems provides us with a unique opportunity to design novel therapeutics to inhibit bone loss in arthritis, periodontal disease, and osteoporosis...
  2. ncbi Osteoclast differentiation and activation
    William J Boyle
    Protein Pathways, Inc, Woodland Hills, California 91367, USA
    Nature 423:337-42. 2003
    ..Further study of this pathway is providing the molecular basis for developing therapeutics to treat osteoporosis and other diseases of bone loss...
  3. ncbi Osteoprotegerin, an endogenous antiosteoclast factor for protecting bone in rheumatoid arthritis
    Brad Bolon
    Amgen, Inc, Thousand Oaks, California 91320, USA
    Arthritis Rheum 46:3121-35. 2002
  4. ncbi Role of RANK ligand in mediating increased bone resorption in early postmenopausal women
    Guitty Eghbali-Fatourechi
    Endocrine Research Unit, Mayo Clinic and Foundation, 200 First Street SW, Rochester, MN 55905, USA
    J Clin Invest 111:1221-30. 2003
    ..The data suggest that upregulation of RANKL on bone marrow cells is an important determinant of increased bone resorption induced by estrogen deficiency...